137 related articles for article (PubMed ID: 34925544)
21. Development and validation of nomograms for epithelial ovarian cancer: a SEER population-based, real-world study.
Wang R; Xie G; Shang L; Qi C; Yang L; Huang L; Li D; Yang W
Future Oncol; 2021 Mar; 17(8):893-906. PubMed ID: 33533669
[No Abstract] [Full Text] [Related]
22. Prognostic impact of marital status on survival of women with epithelial ovarian cancer.
Mahdi H; Kumar S; Munkarah AR; Abdalamir M; Doherty M; Swensen R
Psychooncology; 2013 Jan; 22(1):83-8. PubMed ID: 21919121
[TBL] [Abstract][Full Text] [Related]
23. Conditional disease-free survival rates and their associated determinants in patients with epithelial ovarian cancer: A 15-year retrospective cohort study.
Ebrahimi V; Khalafi-Nezhad A; Ahmadpour F; Jowkar Z
Cancer Rep (Hoboken); 2021 Dec; 4(6):e1416. PubMed ID: 33949809
[TBL] [Abstract][Full Text] [Related]
24. Have racial disparities in ovarian cancer increased over time? An analysis of SEER data.
Terplan M; Schluterman N; McNamara EJ; Tracy JK; Temkin SM
Gynecol Oncol; 2012 Apr; 125(1):19-24. PubMed ID: 22108636
[TBL] [Abstract][Full Text] [Related]
25. Unraveling the etiology of ovarian cancer racial disparity in the deep south: Is it nature or nurture?
Ross J; Braswell KV; Madeira da Silva L; Mujica F; Stutsman S; Finan MA; Nicolson W; Harmon MD; Missanelli M; Cohen A; Singh A; Scalici JM; Rocconi RP
Gynecol Oncol; 2017 May; 145(2):329-333. PubMed ID: 28215839
[TBL] [Abstract][Full Text] [Related]
26. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
Peng Y; Wang H; Huang Q; Wu J; Zhang M
J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063
[TBL] [Abstract][Full Text] [Related]
27. Disparities in ovarian cancer treatment and overall survival according to race: An update.
Huffman DL; Jayakrishnan TT; Shankar K; Peterson CE; Wegner RE
Gynecol Oncol; 2021 Sep; 162(3):674-678. PubMed ID: 34261593
[TBL] [Abstract][Full Text] [Related]
28. Further insights into the role of tumour characteristics in survival of young women with epithelial ovarian cancer.
Elzakkers JCJ; van der Aa MA; van Altena AM; de Hullu JA; Harmsen MG
Gynecol Oncol; 2019 Nov; 155(2):213-219. PubMed ID: 31477282
[TBL] [Abstract][Full Text] [Related]
29. Cardiometabolic comorbidities and epithelial ovarian cancer risk among African-American women in the African-American Cancer Epidemiology Study (AACES).
Staples JN; Peres LC; Camacho F; Alberg AJ; Bandera EV; Barnholtz-Sloan J; Bondy ML; Cote ML; Funkhouser E; Moorman PG; Peters ES; Schwartz AG; Terry PD; Schildkraut JM
Gynecol Oncol; 2020 Jul; 158(1):123-129. PubMed ID: 32362566
[TBL] [Abstract][Full Text] [Related]
30. Racial and socioeconomic disparities in survival among women with advanced-stage ovarian cancer who received systemic therapy.
Washington CJ; Karanth SD; Wheeler M; Aduse-Poku L; Braithwaite D; Akinyemiju TF
Cancer Causes Control; 2024 Mar; 35(3):487-496. PubMed ID: 37874478
[TBL] [Abstract][Full Text] [Related]
31. Comparison of stage III mucinous and serous ovarian cancer: a case-control study.
Firat Cuylan Z; Karabuk E; Oz M; Turan AT; Meydanli MM; Taskin S; Sari ME; Sahin H; Ulukent SC; Akbayir O; Gungorduk K; Gungor T; Kose MF; Ayhan A
J Ovarian Res; 2018 Oct; 11(1):91. PubMed ID: 30376858
[TBL] [Abstract][Full Text] [Related]
32. Adult Glioma Incidence and Survival by Race or Ethnicity in the United States From 2000 to 2014.
Ostrom QT; Cote DJ; Ascha M; Kruchko C; Barnholtz-Sloan JS
JAMA Oncol; 2018 Sep; 4(9):1254-1262. PubMed ID: 29931168
[TBL] [Abstract][Full Text] [Related]
33. Racial disparities in surgical treatment and survival of epithelial ovarian cancer in United States.
Chan JK; Zhang M; Hu JM; Shin JY; Osann K; Kapp DS
J Surg Oncol; 2008 Feb; 97(2):103-7. PubMed ID: 17979133
[TBL] [Abstract][Full Text] [Related]
34. Surgical readmission and survival in women with ovarian cancer: Are short-term quality metrics incentivizing decreased long-term survival?
Barber EL; Rossi EC; Gehrig PA
Gynecol Oncol; 2017 Dec; 147(3):607-611. PubMed ID: 28941658
[TBL] [Abstract][Full Text] [Related]
35. Recent Trends in Ovarian Cancer Incidence and Relative Survival in the United States by Race/Ethnicity and Histologic Subtypes.
Park HK; Ruterbusch JJ; Cote ML
Cancer Epidemiol Biomarkers Prev; 2017 Oct; 26(10):1511-1518. PubMed ID: 28751475
[No Abstract] [Full Text] [Related]
36. Sarcopenia as a predictor of survival and chemotoxicity in patients with epithelial ovarian cancer receiving platinum and taxane-based chemotherapy.
Staley SA; Tucker K; Newton M; Ertel M; Oldan J; Doherty I; West L; Zhang Y; Gehrig PA
Gynecol Oncol; 2020 Mar; 156(3):695-700. PubMed ID: 31928805
[TBL] [Abstract][Full Text] [Related]
37. Prognostic impact of pretreatment thrombocytosis in epithelial ovarian cancer.
Okunade KS; Dawodu O; Adenekan M; Nwogu CM; Awofeso O; Ugwu AO; Salako O; John-Olabode S; Olowoselu OF; Anorlu RI
Niger J Clin Pract; 2020 Aug; 23(8):1141-1147. PubMed ID: 32788493
[TBL] [Abstract][Full Text] [Related]
38. Racial disparities in treatment for pancreatic cancer and impact on survival: a population-based analysis.
Singal V; Singal AK; Kuo YF
J Cancer Res Clin Oncol; 2012 Apr; 138(4):715-22. PubMed ID: 22246279
[TBL] [Abstract][Full Text] [Related]
39. Prognostic Significance of Increased Expression of Annexin A10 (ANXA10) in Serous Epithelial Ovarian Cancer.
Wang J; Zhao S; Wang F; Wang J; Zhang Y
Med Sci Monit; 2019 Jul; 25():5666-5673. PubMed ID: 31363077
[TBL] [Abstract][Full Text] [Related]
40. Racial/Ethnic Disparities in the Incidence of Epithelial Ovarian Cancer in Florida by Histology, 2001-2015: Analysis of Trends.
Westrick A; Schlumbrecht M; Pinheiro P; Hlaing W; Kobetz E; Feaster D; Balise R
South Med J; 2021 Jul; 114(7):395-400. PubMed ID: 34215890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
